Company Filing History:
Years Active: 2018-2025
Title: Jongchan Park: Innovator in Antibody and Display Technology
Introduction
Jongchan Park is a prominent inventor based in Paju-si, South Korea. He has made significant contributions to the fields of biotechnology and display technology, holding a total of 12 patents. His work focuses on developing innovative solutions for cancer treatment and advanced display apparatuses.
Latest Patents
Among his latest patents is the "Anti-beta 1 integrin humanized antibody," which relates to a monoclonal antibody that specifically recognizes and binds to beta 1 integrin as an antigen. This invention also includes a pharmaceutical composition for preventing or treating cancer, utilizing the monoclonal antibody to inhibit the proliferation and angiogenesis of cancer cells while effectively inducing apoptosis. Another notable patent is for a "Display apparatus," which features an active area and a bezel area, incorporating semiconductor patterns and an insulating layer designed to enhance display performance.
Career Highlights
Jongchan Park has worked with notable companies such as LG Display Co., Ltd. and SG Medical Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in both medical and display technologies.
Collaborations
He has collaborated with talented individuals in his field, including Hyunchul Um and JinHwan Kim. These partnerships have fostered a creative environment that has led to the development of groundbreaking technologies.
Conclusion
Jongchan Park's contributions to innovation in antibody technology and display systems highlight his role as a leading inventor. His work continues to impact the fields of medicine and technology, paving the way for future advancements.